TORRANCE, Calif.--(BUSINESS WIRE)--Celprogen Inc., a leader in the Stem Cell Research and Therapeutics industry for stem cell research since 2002, today announced that they have successfully finished printing 3D hearts from flexible Poly Lactic Acid (PLA) material scaffold that was populated with adult human cardiac stem cells. https://www.youtube.com/watch?v=LSCbrlFfTP0.
These 3D printed human hearts were coated and seeded with human adult cardiac stem cells. The 3D scaffold was populated with two T225 human Cardiac Stem Cells 36099-26-T225, and with human adult cardiac cells 36044-15-T225, the scaffold was coated with ECM prior to seeding the cells. This flexible PLA scaffold allows the seeded cardiac stem cells to potentially contract. The 3D print was reduced from adult 17-year-old heart to 1/3 its original size.
The present invention relates to 3D organ printing programs at Celprogen that identifies potential future use in transplant of major organ systems. At present, Celprogen is validating the 3D human printed heart from flexible PLA.
About Celprogen Inc.
Celprogen Inc. is a global Stem Cell Research & Therapeutics company since 2002 , which is developing a proprietary portfolio of unique therapeutics products and life science research tools that includes genetic engineering technologies, stem cell technologies for regenerative medicine, as well as bio-engineering products for tissue & organ transplants. Headquartered in Torrance, California, Celprogen is committed to the research, development, and manufacture of quality Stem Cell, Cancer Stem Cell and Primary Cell Culture products to serve our global community. Additional information about Celprogen is available at http://www.celprogen.com.